Time-of-day radiotherapy alters radiation pneumonitis risk but not survival in lung cancer patients with interstitial lung disease
Therapeutic Advances in Medical Oncology
Published online on May 12, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Lung cancer patients with comorbid interstitial lung disease (ILD) are highly susceptible to radiation pneumonitis (RP) after thoracic radiotherapy (RT). Circadian biology suggests that RT time-of-day (ToD) may influence normal-tissue injury, ...
Background:Lung cancer patients with comorbid interstitial lung disease (ILD) are highly susceptible to radiation pneumonitis (RP) after thoracic radiotherapy (RT). Circadian biology suggests that RT time-of-day (ToD) may influence normal-tissue injury, ...